UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$204M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 3 |
Visa
V
|
+$141M |
| 4 |
Alibaba
BABA
|
+$137M |
| 5 |
Freeport-McMoran
FCX
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$196M |
| 2 |
Infosys
INFY
|
+$163M |
| 3 |
Monster Beverage
MNST
|
+$144M |
| 4 |
Mastercard
MA
|
+$128M |
| 5 |
Procter & Gamble
PG
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14.28% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Humana
HUM
$45B
| $90.1M | 0.09% |
691,242
+15,251
| +2% | +$1.94M |
|
252
Cencora
COR
$60B
| $89.1M | 0.09% |
1,152,285
+303
| +0% | +$23K |
|
253
Seagate
STX
$189B
| $88.2M | 0.09% |
1,539,426
+114,880
| +8% | +$6.8M |
|
|
SNDK
254
DELISTED
SANDISK CORP
SNDK
| $87.1M | 0.09% |
889,134
-182,850
| -17% | -$17.9M |
|
255
CME Group
CME
$95.7B
| $86.9M | 0.09% |
1,086,371
+22,406
| +2% | +$1.69M |
|
256
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.72B
| – | – |
0
| – | – |
|
257
CF Industries
CF
$18.2B
| $85.9M | 0.09% |
1,537,935
-8,055
| -0.5% | -$409K |
|
258
Stryker
SYK
$131B
| $85.8M | 0.09% |
1,062,516
+44,083
| +4% | +$3.63M |
|
259
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $85.6M | 0.08% |
434,460
+67,979
| +19% | +$13.4M |
|
|
MHFI
260
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $84.9M | 0.08% |
1,005,413
+39,021
| +4% | +$3.21M |
|
261
Netflix
NFLX
$305B
| $84.7M | 0.08% |
13,136,410
+263,340
| +2% | +$1.71M |
|
262
Herc Holdings
HRI
$5.48B
| $84.6M | 0.08% |
1,110,192
-18,251
| -2% | -$1.56M |
|
263
Vanguard FTSE Europe ETF
VGK
$30.8B
| $84.2M | 0.08% |
1,525,198
+343,848
| +29% | +$19.9M |
|
264
Western Digital
WDC
$182B
| $83.8M | 0.08% |
1,139,241
+2,395
| +0.2% | +$180K |
|
|
NBL
265
DELISTED
Noble Energy, Inc.
NBL
| $82.8M | 0.08% |
1,211,913
+28,555
| +2% | +$2.03M |
|
266
BioMarin Pharmaceuticals
BMRN
$11.6B
| $82.7M | 0.08% |
1,146,027
+24,253
| +2% | +$1.59M |
|
267
TE Connectivity
TEL
$59.4B
| $81.9M | 0.08% |
1,481,640
+27,581
| +2% | +$1.72M |
|
|
TYC
268
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $81.8M | 0.08% |
1,752,628
+252,408
| +17% | +$11.8M |
|
269
International Paper
IP
$21.9B
| $81.4M | 0.08% |
1,799,799
+45,663
| +3% | +$2.1M |
|
|
SAVE
270
DELISTED
Spirit Airlines, Inc.
SAVE
| $80.9M | 0.08% |
1,170,751
+230,842
| +25% | +$15.8M |
|
|
MNK
271
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $80.2M | 0.08% |
889,737
+331,879
| +59% | +$26M |
|
|
RAI
272
DELISTED
Reynolds American Inc
RAI
| $80.2M | 0.08% |
2,717,590
-59,374
| -2% | -$1.73M |
|
273
VF Corp
VFC
$5.87B
| $79.9M | 0.08% |
1,285,846
+21,621
| +2% | +$1.29M |
|
274
Banco Bradesco
BBD
$39.4B
| $79.9M | 0.08% |
14,311,177
-5,001,013
| -26% | -$31.2M |
|
275
AutoZone
AZO
$48.8B
| $79.8M | 0.08% |
156,561
+232
| +0.1% | +$122K |
|
Similar funds
UBS AM's Q3 2014 Portfolio in Review
As of Q3 2014, UBS AM held 2,623 positions worth $101B, up 1.8% from $99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q3 2014 filing shows 68 new, 1,056 increased, 515 reduced and 65 closed positions. Its largest new stake was Alibaba: 1,521,250 shares worth $135M. The largest sale was Kellanova, an estimated $196M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q3 2014 buy was Alibaba: 1,521,250 shares worth $135M.
- UBS AM added most to Apple in Q3 2014, an estimated $204M increase.
- UBS AM's biggest Q3 2014 reduction was Kellanova, cutting an estimated $196M.
- UBS AM fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $80.9M.
- UBS AM's ten largest holdings make up 15% of its $101B portfolio in Q3 2014.
- UBS AM opened 68 new positions and closed 65 in Q3 2014.
- UBS AM's portfolio value rose 1.8% quarter-over-quarter to $101B.
Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.